Publication | Closed Access
Reactivation of hepatitis and lamivudine therapy in 11 HBsAg‐positive renal allograft recipients: a single centre experience
16
Citations
22
References
2006
Year
For HBsAg (+) renal allograft recipients, careful monitoring of HBV-DNA levels and timely administration of lamivudine could prevent hepatic damage caused by reactivation of hepatitis.
| Year | Citations | |
|---|---|---|
1999 | 1.2K | |
2000 | 695 | |
2001 | 628 | |
2003 | 539 | |
2001 | 418 | |
1998 | 367 | |
2000 | 350 | |
2000 | 202 | |
1996 | 178 | |
2002 | 161 |
Page 1
Page 1